Brendan Hannah

Insider Reports History

Entity
Individual
Location
269 East Grand Ave, South San Francisco, CA
Signature
/s/ Brendan Hannah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brendan Hannah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. CHIEF BUSINESS OFFICER AND COO Common Stock 297K $187K $0.63 Aug 21, 2024 Direct
Quince Therapeutics, Inc. CHIEF BUSINESS OFFICER AND COO Employee Stock Option (right to buy) 47.4K Jun 4, 2024 Direct

Insider Reports Filed by Brendan Hannah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Quince Therapeutics, Inc. Aug 19, 2024 6 $24.2K 4 Aug 21, 2024 CHIEF BUSINESS OFFICER AND COO
QNCX Quince Therapeutics, Inc. Jun 4, 2024 2 $30.8K 4 Jun 5, 2024 CHIEF BUSINESS OFFICER AND COO
QNCX Quince Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 2, 2024 CHIEF BUSINESS OFFICER AND COO
QNCX Quince Therapeutics, Inc. Oct 24, 2023 1 $0 4 Oct 26, 2023 Chief Business Officer and COO
QNCX Quince Therapeutics, Inc. Aug 8, 2023 1 $87.5K 4 Aug 9, 2023 Chief Business Officer
QNCX Quince Therapeutics, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Business Officer
QNCX Cortexyme, Inc. May 19, 2022 1 $0 4/A May 27, 2022 Chief Business Officer
QNCX Cortexyme, Inc. May 19, 2022 0 $0 3 May 23, 2022 Chief Business Officer